Article
GRIN3A defines an immunosuppressive niche in advanced prostate cancer
2025-11-08
Abstract excerpt
<title>Abstract</title> <p>Prostate cancer (PCa) is a highly heterogeneous malignancy characterized by complex progression. In particular, upon progression to castration-resistant prostate cancer (CRPC), the response to immunotherapy is limited, which is primarily attributable to the lack of specific immunotherapeutic targets and biomarkers capable of accurately predicting treatment efficacy. Through systematic i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3790bf59-7949-58f0-922d-890444a0ebeb
- DOI
- 10.21203/rs.3.rs-7574576/v1
